ERBB2 and cancer: Lollini et al. [103] developed SimTriplex, an agent-oriented simulator, to investigate the minimum vaccination (Triplex vaccine) schedule that could afford immunological prevention of cancer in HER-2/neu transgenic mice at par with the currently implemented Chronic (administered for host’s lifetime) protocol.